Groundbreaking research has confirmed that Pittsburgh Compound B binds to the beta-amyloid deposits in the brains of patients with Alzheimer's disease. The finding is a major step toward an early, definitive diagnosis of the memory-stealing condition.
Groundbreaking research has confirmed that Pittsburgh Compound B binds to the beta-amyloid deposits in the brains of patients with Alzheimer's disease. The finding is a major step toward an early, definitive diagnosis of the memory-stealing condition.
"As excited as researchers get, we are pretty excited," said senior author Dr. Steven T. DeKosky, director of the Alzheimer's Disease Research Center at the University of Pittsburgh.
DeKosky and colleagues studied a 63-year-old woman with a clinical diagnosis of AD who underwent PIB-PET imaging and brain autopsy upon her death 10 months later. The regions of her brain with the highest PIB levels before death correlated precisely with those with high beta-amyloid plaque concentration postmortem. An additional 27 brain autopsies confirmed the findings, which investigators reported in the March 12 online issue of Brain.
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.